Pharmacological inhibition in the ataxia telangiectasia and Rad3-similar protein serine/threonine kinase (ATR; also known as FRAP-similar protein (FRP1)) has emerged being a promising system for cancer treatment that exploits synthetic lethal interactions with proteins associated with DNA damage repair service, overcomes resistance to other therapies and enhances antitumour immunity. ... https://alexisydjn30741.blog-mall.com/27249973/considerations-to-know-about-deoxynivalenol